December 28, 2022
December 28, 2022 – TG Therapeutics, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved BriumviTM (ublituximab-xiiy) for the treatment
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Insurance
December 27, 2022
December 27, 2022 - Acer Therapeutics Inc. and its collaboration partner, RELIEF THERAPEUTICS Holding
SA, have announced that the U.S. Food and Drug Administration
December 23, 2022
December 23, 2022 – Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy
December 23, 2022
December 23, 2022 – Xiamen, Fujian, GFA Production (Xiamen) Co., Ltd. is voluntarily recalling one
December 22, 2022
December 22, 2022 - Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for
December 22, 2022
December 22, 2022 - Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Vancomycin
December 22, 2022
December 22, 2022 - Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration
December 22, 2022
December 22, 2022 - Gilead Sciences, Inc. has announced that Sunlenca ® (lenacapavir), in combination with other antiretroviral(s)